Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Highly AccessReview

Developments in the synovial biology field 2006

Anette Knedla email, Elena Neumann email and Ulf Müller-Ladner email

Department for Internal Medicine and Rheumatology, Justus-Liebig-University Giessen, Kerckhoff-Clinic, Bad Nauheim, Benekestr. 2-8, D-61231 Bad Nauheim, Germany

author email corresponding author email

Arthritis Research & Therapy 2007, 9:209doi:10.1186/ar2140

Published: 10 April 2007

Abstract

Synovial pathophysiology is a complex and synergistic interplay of different cell populations with tissue components, mediated by a variety of signaling mechanisms. All of these mechanisms drive the affected joint into inflammation and drive the subsequent destruction of cartilage and bone. Each cell type contributes significantly to the initiation and perpetuation of this deleterious concert, especially in rheumatoid arthritis. Rheumatoid arthritis synovial fibroblasts and macrophages, both cell types with pivotal roles in inflammation and destruction, but also T cells and B cells are crucial for complex network in the inflamed synovium. An even more complex cellular crosstalk between these key players maintains a process of chronic inflammation. As outlined in the present review, in the past year substantial progress has been made to elucidate further details of the rich pathophysiology of rheumatoid arthritis, which may also facilitate the identification of novel targets for future therapeutic strategies.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.